Summary

Persistence Market Research has recently released a comprehensive report on the global Postoperative Pain Management Market, offering a detailed assessment of key market dynamics such as growth drivers, restraints, emerging opportunities, and competitive landscape. The report delivers a thorough overview of market trends and future outlook, enabling healthcare stakeholders and industry participants to make informed strategic decisions.

Key Insights:

• Postoperative Pain Management Market Size (2025E): US$ 45.13 Bn
• Projected Market Value (2032F): US$ 65.22 Bn
• Global Market Growth Rate (CAGR 2025 to 2032): 5.4%

Postoperative Pain Management Market – Report Scope:

The postoperative pain management market comprises pharmaceutical drugs and therapeutic solutions used to manage acute pain following surgical procedures. These products play a vital role in improving patient recovery, reducing hospital stays, and enhancing overall surgical outcomes. The market includes a wide range of analgesics such as opioids, NSAIDs, local anesthetics, and acetaminophen administered through multiple routes including oral, injectable, transdermal, and topical forms. Increasing surgical volumes, advancements in multimodal pain management approaches, and rising awareness regarding effective postoperative care are contributing to the steady expansion of this market across developed and emerging regions.

Market Growth Drivers:

The growth of the global postoperative pain management market is primarily driven by the increasing number of surgical procedures worldwide, fueled by the rising prevalence of chronic diseases, trauma cases, and age-related conditions. Advancements in surgical techniques, including minimally invasive procedures, have increased the demand for effective and fast-acting pain management therapies. Growing awareness among healthcare professionals and patients regarding the importance of proper postoperative pain control to enhance recovery outcomes is further supporting market growth. Additionally, continuous innovation in drug formulations and delivery systems, along with expanding healthcare infrastructure in developing regions, is contributing to sustained market expansion.

Market Restraints:

Despite steady growth prospects, the postoperative pain management market faces several challenges. Concerns related to opioid misuse, addiction, and stringent regulatory policies governing opioid prescriptions pose significant restraints on market growth. Adverse side effects associated with certain pain management drugs, including gastrointestinal complications and cardiovascular risks, may limit their usage. Furthermore, high treatment costs and limited access to advanced pain management therapies in low-income regions can hinder market penetration, particularly in emerging economies.

Market Opportunities:

The postoperative pain management market presents substantial growth opportunities driven by the increasing adoption of multimodal and non-opioid pain management strategies. Growing research and development activities focused on safer analgesics and long-acting local anesthetics offer promising avenues for innovation. Expansion of outpatient and ambulatory surgical centers is creating additional demand for effective pain control solutions. Moreover, rising healthcare investments, improving reimbursement frameworks, and expanding online pharmacy distribution channels in emerging markets are expected to unlock new growth opportunities during the forecast period.

Key Questions Answered in the Report:

• What are the major factors driving the growth of the global postoperative pain management market?
• Which drug classes and routes of administration are witnessing the highest adoption rates?
• How are regulatory policies influencing opioid and non-opioid pain management strategies?
• Who are the key players in the postoperative pain management market, and what strategies are they adopting?
• What are the future trends and growth prospects across major regional markets?

Competitive Intelligence and Business Strategy:

Leading companies operating in the global postoperative pain management market are focusing on product innovation, portfolio expansion, and strategic collaborations to strengthen their market position. These players are investing in research and development to introduce safer, long-acting, and non-opioid pain management solutions. Strengthening hospital partnerships, expanding geographic presence, and enhancing distribution networks remain key strategic priorities. Companies are also emphasizing regulatory compliance and patient-centric pain management approaches to gain a competitive edge in this evolving market landscape.

Competitive Analysis – Companies Covered in This Report:

• Teva Pharmaceutical Industries Ltd
• Novartis AG
• Allergan plc
• GlaxoSmithKline plc
• Mylan N.V.
• Johnson & Johnson
• Pfizer Inc.
• Purdue Pharma L.P
• Janssen Pharmaceuticals, Inc
• Endo International plc
• Baxter International
• Pacira Pharmaceuticals Inc.
• Cadila Healthcare Limited
• Cipla Limited
• Eisan
• LG Chem
• AbbVie Inc.
• Amgen Inc.
• Sun Pharmaceutical Ltd.

Postoperative Pain Management Market Segmentation

By Drug

• Opioids
• NSAIDs
• Local Anesthetics
• Acetaminophen

By Route of Administration

• Injectable
• Oral
• Rectal
• Topical
• Transdermal
• Others

By Prescription Type

• Over-the-counter (OTC) Products
• Prescription Drugs

By Distribution Channel

• Hospital Pharmacies
• Specialty Clinics
• Long Term Care Centers
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Postoperative Pain Management Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors – Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter’s Five Force Analysis
4. Global Postoperative Pain Management Market Outlook
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025–2032
4.3. Global Postoperative Pain Management Market Outlook: Drug
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Drug, 2019-2024
4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
4.3.3.1. Opioids
4.3.3.1.1. Tramadol
4.3.3.1.2. Oxycodone
4.3.3.1.3. Hydrocodone
4.3.3.1.4. Other Opioids
4.3.3.2. NSAIDs
4.3.3.3. Local Anesthetics
4.3.3.4. Acetaminophen
4.3.4. Market Attractiveness Analysis: Drug
4.4. Global Postoperative Pain Management Market Outlook: Route of Administration
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2019-2024
4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
4.4.3.1. Injectable
4.4.3.2. Oral
4.4.3.3. Rectal
4.4.3.4. Topical
4.4.3.5. Transdermal
4.4.3.6. Others
4.4.4. Market Attractiveness Analysis: Route of Administration
4.5. Global Postoperative Pain Management Market Outlook: Prescription Type
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By Prescription Type, 2019-2024
4.5.3. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
4.5.3.1. Over-The-Counter (OTC) Products
4.5.3.2. Prescription Drugs
4.5.4. Market Attractiveness Analysis: Prescription Type
4.6. Global Postoperative Pain Management Market Outlook: Distribution Channel
4.6.1. Introduction / Key Findings
4.6.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2024
4.6.3. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
4.6.3.1. Hospital Pharmacies
4.6.3.2. Specialty Clinics
4.6.3.3. Long Term Care Centers
4.6.3.4. Retail Pharmacies
4.6.3.5. Drug Stores
4.6.3.6. Online Pharmacies
4.6.4. Market Attractiveness Analysis: Distribution Channel
5. Global Postoperative Pain Management Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Postoperative Pain Management Market Outlook
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
6.2.1. By Country
6.2.2. By Drug
6.2.3. By Route of Administration
6.2.4. By Prescription Type
6.2.5. By Distribution Channel
6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
6.3.1. U.S.
6.3.2. Canada
6.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
6.4.1. Opioids
6.4.1.1. Tramadol
6.4.1.2. Oxycodone
6.4.1.3. Hydrocodone
6.4.1.4. Other Opioids
6.4.2. NSAIDs
6.4.3. Local Anesthetics
6.4.4. Acetaminophen
6.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
6.5.1. Injectable
6.5.2. Oral
6.5.3. Rectal
6.5.4. Topical
6.5.5. Transdermal
6.5.6. Others
6.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
6.6.1. Over-The-Counter (OTC) Products
6.6.2. Prescription Drugs
6.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
6.7.1. Hospital Pharmacies
6.7.2. Specialty Clinics
6.7.3. Long Term Care Centers
6.7.4. Retail Pharmacies
6.7.5. Drug Stores
6.7.6. Online Pharmacies
6.8. Market Attractiveness Analysis
7. Europe Postoperative Pain Management Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Drug
7.2.3. By Route of Administration
7.2.4. By Prescription Type
7.2.5. By Distribution Channel
7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Rest of Europe
7.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
7.4.1. Opioids
7.4.1.1. Tramadol
7.4.1.2. Oxycodone
7.4.1.3. Hydrocodone
7.4.1.4. Other Opioids
7.4.2. NSAIDs
7.4.3. Local Anesthetics
7.4.4. Acetaminophen
7.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
7.5.1. Injectable
7.5.2. Oral
7.5.3. Rectal
7.5.4. Topical
7.5.5. Transdermal
7.5.6. Others
7.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
7.6.1. Over-The-Counter (OTC) Products
7.6.2. Prescription Drugs
7.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
7.7.1. Hospital Pharmacies
7.7.2. Specialty Clinics
7.7.3. Long Term Care Centers
7.7.4. Retail Pharmacies
7.7.5. Drug Stores
7.7.6. Online Pharmacies
7.8. Market Attractiveness Analysis
8. East Asia Postoperative Pain Management Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Drug
8.2.3. By Route of Administration
8.2.4. By Prescription Type
8.2.5. By Distribution Channel
8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
8.4.1. Opioids
8.4.1.1. Tramadol
8.4.1.2. Oxycodone
8.4.1.3. Hydrocodone
8.4.1.4. Other Opioids
8.4.2. NSAIDs
8.4.3. Local Anesthetics
8.4.4. Acetaminophen
8.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
8.5.1. Injectable
8.5.2. Oral
8.5.3. Rectal
8.5.4. Topical
8.5.5. Transdermal
8.5.6. Others
8.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
8.6.1. Over-The-Counter (OTC) Products
8.6.2. Prescription Drugs
8.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
8.7.1. Hospital Pharmacies
8.7.2. Specialty Clinics
8.7.3. Long Term Care Centers
8.7.4. Retail Pharmacies
8.7.5. Drug Stores
8.7.6. Online Pharmacies
8.8. Market Attractiveness Analysis
9. South Asia & Oceania Postoperative Pain Management Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Drug
9.2.3. By Route of Administration
9.2.4. By Prescription Type
9.2.5. By Distribution Channel
9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
9.4.1. Opioids
9.4.1.1. Tramadol
9.4.1.2. Oxycodone
9.4.1.3. Hydrocodone
9.4.1.4. Other Opioids
9.4.2. NSAIDs
9.4.3. Local Anesthetics
9.4.4. Acetaminophen
9.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
9.5.1. Injectable
9.5.2. Oral
9.5.3. Rectal
9.5.4. Topical
9.5.5. Transdermal
9.5.6. Others
9.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
9.6.1. Over-The-Counter (OTC) Products
9.6.2. Prescription Drugs
9.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
9.7.1. Hospital Pharmacies
9.7.2. Specialty Clinics
9.7.3. Long Term Care Centers
9.7.4. Retail Pharmacies
9.7.5. Drug Stores
9.7.6. Online Pharmacies
9.8. Market Attractiveness Analysis
10. Latin America Postoperative Pain Management Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Drug
10.2.3. By Route of Administration
10.2.4. By Prescription Type
10.2.5. By Distribution Channel
10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
10.4.1. Opioids
10.4.1.1. Tramadol
10.4.1.2. Oxycodone
10.4.1.3. Hydrocodone
10.4.1.4. Other Opioids
10.4.2. NSAIDs
10.4.3. Local Anesthetics
10.4.4. Acetaminophen
10.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
10.5.1. Injectable
10.5.2. Oral
10.5.3. Rectal
10.5.4. Topical
10.5.5. Transdermal
10.5.6. Others
10.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
10.6.1. Over-The-Counter (OTC) Products
10.6.2. Prescription Drugs
10.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
10.7.1. Hospital Pharmacies
10.7.2. Specialty Clinics
10.7.3. Long Term Care Centers
10.7.4. Retail Pharmacies
10.7.5. Drug Stores
10.7.6. Online Pharmacies
10.8. Market Attractiveness Analysis
11. Middle East & Africa Postoperative Pain Management Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Drug
11.2.3. By Route of Administration
11.2.4. By Prescription Type
11.2.5. By Distribution Channel
11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
11.4.1. Opioids
11.4.1.1. Tramadol
11.4.1.2. Oxycodone
11.4.1.3. Hydrocodone
11.4.1.4. Other Opioids
11.4.2. NSAIDs
11.4.3. Local Anesthetics
11.4.4. Acetaminophen
11.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
11.5.1. Injectable
11.5.2. Oral
11.5.3. Rectal
11.5.4. Topical
11.5.5. Transdermal
11.5.6. Others
11.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
11.6.1. Over-The-Counter (OTC) Products
11.6.2. Prescription Drugs
11.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
11.7.1. Hospital Pharmacies
11.7.2. Specialty Clinics
11.7.3. Long Term Care Centers
11.7.4. Retail Pharmacies
11.7.5. Drug Stores
11.7.6. Online Pharmacies
11.8. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2024
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
12.3.1. Teva Pharmaceutical Industries Ltd
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Novartis AG
12.3.3. Allergan plc
12.3.4. GlaxoSmithKline plc
12.3.5. Mylan N.V.
12.3.6. Johnson & Johnson
12.3.7. Pfizer Inc.
12.3.8. Purdue Pharma L.P
12.3.9. Janssen Pharmaceuticals, Inc
12.3.10. Endo International plc
12.3.11. Baxter International
12.3.12. Pacira Pharmaceuticals Inc.
12.3.13. Cadila Healthcare Limited
12.3.14. Cipla Limited
12.3.15. Eisan
12.3.16. LG Chem
12.3.17. AbbVie Inc.
12.3.18. Amgen Inc.
12.3.19. Sun Pharmaceutical Ltd.
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations